Monograph
S01EE05 - Tafluprost |
Not porphyrinogenic |
NP |
Rationale
Administered locally in the eye and systemic exposure is insignificant.
Chemical description
Fluorinated analog of prostaglandin F2-alpha.
Therapeutic characteristics
Tafluprost eye drops reduce elevated intraocular pressure in open angle glaucoma and ocular hypertension.
Hepatic exposure
Mean plasma tafluprost acid concentrations were below the limit of quantification of the bioanalytical assay (10 pg/mL) and hepatic exposure is therefore insignificant (SPC).
Metabolism and pharmacokinetics
Tafluprost is a prodrug and is hydrolyzed to the pharmacologically active metabolite, tafluprost acid. Tafluprost acid is further metabolized by glucuronidation and beta-oxidation. CYP450 enzymes are not involved in the metabolism.
Similar drugs
References
| # | Citation details | PMID |
|---|---|---|
| * | Summary of Product Characteristics | |
| 1. | The electronic Medicines Compendium (emc). Summary of Product Characteristics (SPC). Saflutan.
|
|
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Saflutan 
Saflutan 
Saflutan · Taflotan 
Safluround · Saflutan 
Saflutan 
Saflutan · Taflotan 
Saflutan · Taflotan · Tafluprost 
Taflotan 
Taflotan 
Saflutan · Tafluprost 
Taflotan 
Taflotan · Tafluprost 
Taflotan 
Saflutan
© NAPOS 2025